BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29649105)

  • 1. Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis.
    Takemura M; Nakahara T; Hashimoto-Hachiya A; Furue M; Tsuji G
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis.
    Miake S; Tsuji G; Takemura M; Hashimoto-Hachiya A; Vu YH; Furue M; Nakahara T
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
    Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.
    Park SJ; Im DS
    Acta Pharmacol Sin; 2020 Nov; 41(11):1487-1496. PubMed ID: 32457418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of a histamine 4 receptor antagonist on CCL17 and CCL22 production by monocyte-derived Langerhans cells in patients with atopic dermatitis.
    Miyano K; Matsushita S; Tsuchida T; Nakamura K
    J Dermatol; 2016 Sep; 43(9):1024-9. PubMed ID: 26892271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
    Hashimoto S; Nakamura K; Oyama N; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
    J Dermatol Sci; 2006 Nov; 44(2):93-9. PubMed ID: 17008059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H; Takahashi M; Nakamura K; Kaneko F
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor.
    Takei K; Mitoma C; Hashimoto-Hachiya A; Uchi H; Takahara M; Tsuji G; Kido-Nakahara M; Nakahara T; Furue M
    J Dermatol; 2015 Feb; 42(2):171-80. PubMed ID: 25482884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulvic Acid Attenuates Atopic Dermatitis by Downregulating CCL17/22.
    Wu C; Lyu A; Shan S
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6.
    Williams TC; Jackson DJ; Maltby S; Walton RP; Ching YM; Glanville N; Singanayagam A; Brewins JJ; Clarke D; Hirsman AG; Loo SL; Wei L; Beale JE; Casolari P; Caramori G; Papi A; Belvisi M; Wark PAB; Johnston SL; Edwards MR; Bartlett NW
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):344-356. PubMed ID: 33264064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
    Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
    Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
    Furue M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.
    Liddiard K; Welch JS; Lozach J; Heinz S; Glass CK; Greaves DR
    BMC Mol Biol; 2006 Nov; 7():45. PubMed ID: 17134490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis.
    Tsuji G; Hashimoto-Hachiya A; Kiyomatsu-Oda M; Takemura M; Ohno F; Ito T; Morino-Koga S; Mitoma C; Nakahara T; Uchi H; Furue M
    Cell Death Dis; 2017 Jul; 8(7):e2931. PubMed ID: 28703805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
    Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin.
    Matsui K; Nishikawa A
    J Investig Allergol Clin Immunol; 2011; 21(5):354-62. PubMed ID: 21905498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33-activated dendritic cells induce the production of thymus and activation-regulated chemokine and macrophage-derived chemokine.
    Kurokawa M; Matsukura S; Kawaguchi M; Ieki K; Suzuki S; Watanabe S; Homma T; Yamaguchi M; Takeuchi H; Adachi M
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():52-7. PubMed ID: 23711854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CCR4 antagonist ameliorates atopic dermatitis-like skin lesions induced by dibutyl phthalate and a hydrogel patch containing ovalbumin.
    Matsuo K; Hatanaka S; Kimura Y; Hara Y; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Kabashima K; Nakayama T
    Biomed Pharmacother; 2019 Jan; 109():1437-1444. PubMed ID: 30551395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.
    van den Bogaard EH; Bergboer JG; Vonk-Bergers M; van Vlijmen-Willems IM; Hato SV; van der Valk PG; Schröder JM; Joosten I; Zeeuwen PL; Schalkwijk J
    J Clin Invest; 2013 Feb; 123(2):917-27. PubMed ID: 23348739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.
    Cordiglieri C; Marolda R; Franzi S; Cappelletti C; Giardina C; Motta T; Baggi F; Bernasconi P; Mantegazza R; Cavalcante P
    J Autoimmun; 2014 Aug; 52():74-89. PubMed ID: 24397961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.